AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...

SL BIO Ltd. ("SL Bio" or the “Company”), a biomedical company specializing in developing innovative cellular and gene therapies, and Horizon Space Acquisition II Corp. (Nasdaq: HSPT) ("HSPT"), a ...

CARsgen and Dispatch Bio ink clinical collaboration to evaluate flare platform and zevor-cel in solid tumours: Shanghai Wednesday, January 14, 2026, 18:00 Hrs [IST] CARsgen Therap ...

The collaboration will leverage Abalone Bio’s Functional Antibody Selection Technology platform for an undisclosed ...

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...

Intelligent Bio Solutions stock rises after announcing a manufacturing partnership targeting over 40% cost savings, major ...

Solid Biosciences (SLDB) traded higher on Wednesday after the gene therapy developer announced full enrollment in a Phase 1/2 study for its lead candidate SGT-003 in children with a muscle-wasting ...

The medical biotechnology company built a 100,000-square-foot lab near the airport to receive, treat and send blood cancer ...

Instil Bio said its subsidiary has discontinued clinical development of AXN-2510 and terminated its collaboration agreement with ImmuneOnco Biopharmaceuticals (Shanghai) for AXN-2510 and AXN-27M.

Learn how spectroscopy facilitates non-invasive, real-time bio-monitoring, enhancing decision-making in healthcare, ...